HZ and its complications impose a significant burden on patients and the private healthcare sector in Vietnam. Older age, comorbidities, immunodeficiency, and hospitalization were identified as key cost drivers in HZ management. The findings reflect the importance of introducing new management options to reduce the economic burden of HZ, and could support decision-making related to HZ prevention.
Ahmed et al. (Thu,) studied this question.